Detalhe da pesquisa
1.
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.
Breast Cancer Res Treat
; 190(3): 415-424, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34546500
2.
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX.
Ann Oncol
; 27(6): 1055-1061, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27002107
3.
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.
Ann Oncol
; 25(9): 1756-1761, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24942275
4.
Aggressive treatment for hepatic metastases from breast cancer: results from a single center.
World J Surg
; 37(6): 1322-32, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23474856
5.
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study.
ESMO Open
; 8(1): 100748, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36603521
6.
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients.
Sci Rep
; 13(1): 12255, 2023 07 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37507480
7.
A novel germline mutation in peroxisome proliferator-activated receptor gamma gene associated with large intestine polyp formation and dyslipidemia.
Biochim Biophys Acta
; 1802(6): 572-81, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20123124
8.
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
Breast
; 48: 7-16, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31470257
9.
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial.
ESMO Open
; 1(6): e000086, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-28848656
10.
The high expression of p53 in sporadic colorectal carcinoma is associated with metastasis and decreased survival.
Pathologica
; 102(2): 51-6, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23596757
11.
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group.
Br J Cancer
; 96(11): 1639-43, 2007 Jun 04.
Artigo
Inglês
| MEDLINE | ID: mdl-17486128
12.
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer.
Br J Cancer
; 92(9): 1621-5, 2005 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-15856035